loading

Finanzdaten der Unity Biotechnology Inc-Aktie (UBX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
1.02%
7.599
7.677 14.58 11.85 10.56
Interest Income/Expense
100.00%
-
0.001 0.566 0.883 1.002
Operating Income/Loss
1.02%
-7.599
-7.677 -14.58 -11.85 -10.56
Income/Loss From Continuing Operations Before Tax
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Income/Loss From Continuing Operations After Tax
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Net Income/Loss
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,034%
16.79
0.3269 14.60 14.43 14.31
Diluted Average Shares
5,034%
16.79
0.3269 14.60 14.43 14.31
Basic Earnings Per Share
41.67%
-0.34
-0.24 -1.01 -1.07 -0.37
Diluted Earnings Per Share
41.67%
-0.34
-0.24 -1.01 -1.07 -0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.36
price down icon 1.88%
$72.65
price down icon 0.68%
$23.34
price up icon 5.20%
$370.48
price up icon 0.61%
biotechnology ONC
$215.60
price down icon 1.09%
$116.42
price down icon 0.66%
Kapitalisierung:     |  Volumen (24h):